Maggi ban not in retaliation to EU's clampdown on GVK
Government on Friday rejected suggestions that the five-month ban Swiss giant Nestle's Maggi noodles was in retaliation to EU's clampdown on marketing of 700 generic drugs for alleged manipulation of clinical trials by GVK Bio.
Mar 04, 2016, 22:27 PM IST
GVK Bio offers to re-do studies after EU ruling
Pharmaceutical research company GVK Biosciences has offered to re-do studies at its own cost after the European Union suspended marketing approval of some generic drugs due to alleged manipulation of data related to clinical trials.
Dec 08, 2014, 19:49 PM IST
